New CKS for Dupuytren’s disease
The NHS Clinical Knowledge Summaries has published a new topic which covers the management of Dupuytren’s disease and contracture in primary care. This CKS topic does not cover, in any detail, the management of Dupuytren’s contracture in secondary care. The target audience for this CKS topic is healthcare professionals working within the NHS in England, and providing first contact or primary health care but is useful information for all health care professionals.
Dupuytren’s disease is a benign, slowly progressive fibroproliferative disorder. It is characterized by the formation of nodules, usually in the palm of the hand, followed by cords of connective tissue extending towards the fingers. Over months to years, the cords contract, resulting in flexion contracture of the fingers and reduced hand function.
Dupuytren’s disease belongs to the group of fibromatoses which also includes plantar fibromatosis (Ledderhose disease), penile fibromatosis (Peyronie’s disease), and fibromatosis of the dorsum of the proximal interphalangeal joints (Garrod’s knuckle pads).
The NHS Clinical Knowledge Summaries are a reliable source of evidence-based information and practical ‘know how’ about the common conditions managed in primary care. CKS is commissioned and paid for by NHS Evidence, a service provided by the National Institute for Health and Clinical Excellence. CKS is aimed at healthcare professionals working in primary and first-contact care.
Related posts:
- Mobilizing the Stiff Hand: Combining Theory and Evidence to Improve Clinical Outcomes
- There is inadequate evidence to determine the effectiveness of nonpharmacological and nonsurgical interventions for hand osteoarthritis: an overview of high-quality systematic reviews
- Diagnostic Value of Clinical Grind Test for Carpometacarpal Osteoarthritis of the Thumb.
- Responsiveness of the Michigan Hand Outcomes Questionnaire and the Disabilities of the Arm, Shoulder, and Hand Questionnaire in Patients With Hand Injury
- A six-week hand exercise programme improves strength and hand function in patients with rheumatoid arthritis.
Return to top of page